Health

Backing pioneers who are transforming the health industry from digital therapeutics through to biotechnology.

Portfolio

Team

Our latest insights and news

10 Jun 2021

Our investment in Overture

Who are the pioneers? Overture was co-founded by Martin Varsavsky (CEO) in 2017. Martin is a serial entrepreneur who has built and exited several…
Written by Luke Hakes
Read more
18 Mar 2021

Our investment in Wefarm

We always want to back the boldest, most mission-driven companies, and they don’t come more pioneering than Wefarm. Since its founding in 2015,…
Written by Kamran Adle
Read more

In the press

Writing in The Times Uzma Choudry explains why the vaccine model needs to change

Stopping pandemics requires humanitarian intentions, but until we disrupt the model that holds pharma accountable to profit, this will never come first.

Read more

As fertility rates continue to decline not everyone has access to treatment

The Telegraph reports on Kamran’s research into the funds raised by fertility startups looking at innovative ways to tackle the issue.

Read more

Will Gibbs reveals to TechCrunch how taboo healthcare subjects have huge potential markets

Cultural and institutional stigma has kept parts of healthcare out of sight and out of mind to all but the boldest entrepreneurs.

Read more

How tech will tackle health’s neglected problems

Will tells The New Scientist why we’re backing the tech pioneers who are tackling health’s biggest – but neglected – problems.

Read more

Elvie’s femtech revolution

The Telegraph reports on Femtech superstar, Tania Boler.

Read more

Mental health investment reaches record high

Forbes reports on Kamran’s research into an area that presents massive potential for innovators and disruptors.

Read more

Portfolio support

Building a business is hard. So we’ve created a structure that best supports founders to face all challenges head on.

Find out more

Sign up to the Octopus Ventures newsletter

For our latest insights and news